Lilly creates new drug discovery initiative
INDIANAPOLIS A U.S. drug maker has created a new drug discovery initiative that will use its disease-state analyses and a secure Web portal to look for potential new drugs in university and biotechnology labs.
Eli Lilly & Co. announced Monday that findings from its PD2 initiative, pronounced “PD-squared” and short for the Lilly Phonotypic Drug Discovery Initiative, could lead to partnerships between the Indianapolis-based pharmaceutical company and other institutions to develop drugs that treat Alzheimer’s disease, cancer, diabetes and osteoporosis.
“Each year, researchers throughout the world design and synthesize compounds in university and biotechnology laboratories that are never fully evaluated as potential drug candidates,” Lilly VP discovery chemistry research and technologies Alan Palkowitz said. “There’s an untapped source of ideas and compounds in the greater scientific community that could ultimately impact patients’ lives following further evaluation and development.”
Maryland offers free prescription card to residents
ANNAPOLIS, Md. Maryland earlier this week launched a new statewide discount drug card program, called the Maryland Rx Card. The program, free to all Maryland residents, will provide savings of up to 75% on prescription drugs, though savings should average roughly 30%.
The program has no restrictions to membership, including no income requirements and no age limitations, and will be accepted at more than 50,000 pharmacy locations across the country.
Novo Nordisk discusses diabetes costs, patient motivation at conference
WASHINGTON The cost of diabetes to the country and the lag in patient motivation to take action to offset it were the major themes at a conference sponsored recently by a drug maker focused on the disease.
Danish drug maker Novo Nordisk convened the conference in Washington, bringing in such speakers as American Diabetes Association CEO Larry Hausner.
Without intervention at the national and patient level, the company said, the country runs the risk of having 50 million people living with the disease by 2025.
“The growing prevalence of diabetes is having a profound effect on the health of current and future generations, as well as our national economy,” Hausner said. “We must awaken the public’s consciousness of diabetes and ensure our leaders in Congress recognize healthcare reform as their opportunity to transform the lives of all people affected by this devastating disease.”